Sinopharm Group (SHTDF) Stock Price, News & Analysis

Company Overview

Sinopharm Group Co., Ltd. is a China-based healthcare company and a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm). The company primarily operates as a pharmaceutical and medical-products distributor, supplying hospitals, pharmacies, clinics and other healthcare institutions.

Its business activities include the distribution of prescription and over-the-counter medicines, traditional Chinese medicines, vaccines, medical devices, diagnostic products and other healthcare-related goods. Sinopharm Group also operates pharmaceutical retail businesses, logistics and supply-chain services, and related healthcare distribution operations.

Established in 2003 and listed on the Hong Kong Stock Exchange in 2009, the company serves customers throughout mainland China through an extensive distribution and logistics network. Its operations support the procurement and delivery of medicines and medical products from manufacturers to healthcare providers and patients.

Key Stats

• Today's Range: $1.90 to $2.08
• 50-Day Range: $1.82 to $2.15
• 52-Week Range: $1.82 to $2.70
• Volume: 34,766 shs
• Average Volume: 101,745 shs
• Market Capitalization: N/A
• P/E Ratio: 2.08
• Dividend Yield: 12.50%
• Price Target: N/A
• Consensus Rating: N/A

Sinopharm Group Stock Analysis - MarketRank™

Sinopharm Group scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sinopharm Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sinopharm Group is 2.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.27.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sinopharm Group is 2.08, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 213.99.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sinopharm Group has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Sinopharm Group has recently decreased by 0.49%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Sinopharm Group pays a meaningful dividend of 1.11%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sinopharm Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sinopharm Group is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Sinopharm Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sinopharm Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

16.47% of the stock of Sinopharm Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHTDF
• CIK: 1556605
• Web: ir.sinopharmgroup.com.cn
• Phone: 86-21-2305-2666
• Fax: N/A
• Employees: 115,959
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 2.08
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A